Income Statement
12 months ended: | Revenues | Net income attributable to HCA Healthcare, Inc. |
---|---|---|
Dec 31, 2021 | 58,752) | 6,956) |
Dec 31, 2020 | 51,533) | 3,754) |
Dec 31, 2019 | 51,336) | 3,505) |
Dec 31, 2018 | 46,677) | 3,787) |
Dec 31, 2017 | 43,614) | 2,216) |
Dec 31, 2016 | 41,490) | 2,890) |
Dec 31, 2015 | 39,678) | 2,129) |
Dec 31, 2014 | 36,918) | 1,875) |
Dec 31, 2013 | 34,182) | 1,556) |
Dec 31, 2012 | 33,013) | 1,605) |
Dec 31, 2011 | 29,682) | 2,465) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
- Revenues:
- The revenues of HCA Healthcare Inc. have shown a steady growth trend over the years, increasing from 29,682 million USD in 2011 to 58,752 million USD in 2021. The growth has been consistent with a gradual rise in each year.
- Net income attributable to HCA Healthcare, Inc.:
- The net income attributable to HCA Healthcare, Inc. has displayed some variability during the period. There was a significant increase from 2011 to 2012, followed by fluctuations in the subsequent years. The highest recorded net income was 6,956 million USD in 2021.
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2021 | 13,542) | 50,742) |
Dec 31, 2020 | 12,333) | 47,490) |
Dec 31, 2019 | 11,196) | 45,058) |
Dec 31, 2018 | 10,213) | 39,207) |
Dec 31, 2017 | 9,977) | 36,593) |
Dec 31, 2016 | 9,086) | 33,758) |
Dec 31, 2015 | 9,232) | 32,744) |
Dec 31, 2014 | 8,930) | 31,199) |
Dec 31, 2013 | 8,037) | 28,831) |
Dec 31, 2012 | 7,763) | 28,075) |
Dec 31, 2011 | 7,233) | 26,898) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
- Current Assets:
- The trend in current assets shows a consistent increase from 2011 to 2021. There is a steady growth in the value of current assets over the period, with a notable rise in recent years.
- Total Assets:
- Total assets demonstrate a similar pattern of growth as current assets, reflecting a steady upward trajectory from 2011 to 2021. The values have increased significantly, indicating the company's expanding asset base.
Balance Sheet: Liabilities and Stockholders’ Equity
HCA Healthcare Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
Current liabilities | Long-term debt | Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. | |
---|---|---|---|
Dec 31, 2021 | 9,582) | 34,579) | (933) |
Dec 31, 2020 | 8,704) | 31,004) | 572) |
Dec 31, 2019 | 7,757) | 33,722) | (2,808) |
Dec 31, 2018 | 7,569) | 32,821) | (4,950) |
Dec 31, 2017 | 6,158) | 33,058) | (6,806) |
Dec 31, 2016 | 5,834) | 31,376) | (7,302) |
Dec 31, 2015 | 5,516) | 30,488) | (7,599) |
Dec 31, 2014 | 5,480) | 29,645) | (7,894) |
Dec 31, 2013 | 5,695) | 28,376) | (8,270) |
Dec 31, 2012 | 6,172) | 28,930) | (9,660) |
Dec 31, 2011 | 5,554) | 27,052) | (8,258) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
- Current Liabilities
- Current liabilities showed a fluctuating trend from 2011 to 2021, with a peak value in 2019 at US$7.757 billion before a slight decrease by the end of 2021 to US$9.582 billion.
- Long-term Debt
- Long-term debt exhibited an overall increasing trend over the period, reaching the highest level in 2021 at US$34.579 billion.
- Stockholders' Equity (Deficit) attributable to HCA Healthcare, Inc.
- Stockholders' equity underwent improvements from deficit to positive values, with a significant turnaround from a deficit of US$9.660 billion in 2012 to US$572 million in 2020, followed by a slight decrease to a deficit of US$933 million in 2021.
Cash Flow Statement
12 months ended: | Net cash provided by operating activities | Net cash used in investing activities | Net cash used in financing activities |
---|---|---|---|
Dec 31, 2021 | 8,959) | (2,643) | (6,655) |
Dec 31, 2020 | 9,232) | (3,393) | (4,677) |
Dec 31, 2019 | 7,602) | (5,720) | (1,771) |
Dec 31, 2018 | 6,761) | (3,901) | (3,075) |
Dec 31, 2017 | 5,426) | (4,279) | (1,061) |
Dec 31, 2016 | 5,653) | (3,240) | (2,508) |
Dec 31, 2015 | 4,734) | (2,583) | (1,976) |
Dec 31, 2014 | 4,448) | (2,918) | (1,378) |
Dec 31, 2013 | 3,680) | (2,346) | (1,625) |
Dec 31, 2012 | 4,175) | (2,063) | (1,780) |
Dec 31, 2011 | 3,933) | (2,995) | (976) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
- Net cash provided by operating activities
- The trend in net cash provided by operating activities has generally shown an increasing pattern over the period from 2011 to 2021. There was a notable rise from 2011 to 2013, followed by fluctuations in the subsequent years with a peak in 2020 before a slight decrease in 2021.
- Net cash used in investing activities
- The data indicates that net cash used in investing activities experienced fluctuations over the years, with both positive and negative values recorded. There was a significant decrease from 2011 to 2012, followed by varied movements. The trend shows an overall decrease from 2018 to 2020, with a slight uptick in 2021.
- Net cash used in financing activities
- The trend in net cash used in financing activities reveals fluctuations throughout the period under review, with some years showing negative values indicating financing inflows. There was a notable decrease from 2011 to 2012, followed by mixed movements in subsequent years. The data suggests a substantial increase in financing activities in 2021 compared to the preceding years.
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2021 | 21.52 | 21.16 | 1.92 |
Dec 31, 2020 | 11.10 | 10.93 | 0.43 |
Dec 31, 2019 | 10.27 | 10.07 | 1.60 |
Dec 31, 2018 | 10.90 | 10.66 | 1.40 |
Dec 31, 2017 | 6.12 | 5.95 | 0.00 |
Dec 31, 2016 | 7.53 | 7.30 | 0.00 |
Dec 31, 2015 | 5.14 | 4.99 | 0.00 |
Dec 31, 2014 | 4.30 | 4.16 | 0.00 |
Dec 31, 2013 | 3.50 | 3.37 | 0.00 |
Dec 31, 2012 | 3.65 | 3.49 | 0.00 |
Dec 31, 2011 | 5.17 | 4.97 | 0.00 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
- Basic Earnings Per Share:
- Steady increase from 2011 to 2016, with a significant rise from 2016 to 2021.
- Diluted Earnings Per Share:
- Similar pattern to Basic EPS, showing a consistent climb over time.
- Dividend Per Share:
- No data until 2018, a jump in 2019, then a sharp decrease in 2020, followed by a notable increase in 2021.